Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bernard Escudier(Institut Gustave Roussy), Vesa Kataja(South Eastern Finland University of Applied Sciences), Peter F.A. Mulders(Radboud University Nijmegen), Vincent Khoo(The University of Texas MD Anderson Cancer Center), Ferrán Algaba(Puigvert Foundation), Camillo Porta(University of Pavia), J.-J. Patard(Bicêtre Hospital), Tim Eisen(NIHR Cambridge Biomedical Research Centre)
Cited by 275
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k